P&G–Gillette: How a Failed $50 Offer Became a 0.975 Merger
A case study of how Procter & Gamble and Gillette reopened a failed negotiation, shifted from a dollar offer to a fixed stock ratio, and priced executive transition and FTC remedies into the deal.
The first offer had already failed. Procter & Gamble had proposed roughly $50 per Gillette share in December 2004, and Gillette had rejected the proposal. Six weeks later, the companies signed an all-stock merger at a fixed exchange ratio of 0.975 P&G shares for each Gillette share. 1 What changed: the value of Gillette, the bargaining power of the parties, or the design of the deal?
Deal snapshot
| Question | Answer |
|---|---|
| Parties | The Procter & Gamble Company and The Gillette Company. The merger agreement was signed on January 27, 2005, and the transaction was announced on January 28. 1 |
| Consideration | 0.975 P&G common shares for each Gillette share, in an all-stock transaction designed to qualify as tax-free for Gillette shareholders. 1 |
| Ownership after closing | P&G shareholders: approximately 71% of the combined company. Gillette shareholders: approximately 29%. 1 |
| Announced value | Approximately $57 billion, based on the value stated when the deal was announced. 2 |
| Expected value creation | P&G announced $14–$16 billion in present value of revenue and cost synergies; the proxy also described more than $1 billion in annual cost synergies by year three. 12 |
The headline value and the accounting value serve different purposes. P&G later recorded approximately $53.43 billion of purchase consideration, including common stock, vested options, and acquisition costs. 3
Why Gillette entered the conversation
Gillette had built a large business around blades and razors, and its board had been reviewing strategic options before P&G became the buyer. The proxy records an April 2002 approach to another major consumer-products company. Discussions in 2002 and again in the summer of 2004 ended amid disagreements over valuation, management, and culture. 1
The earlier attempts matter because they define the seller's negotiating position. Gillette had a valuable franchise and a stand-alone path. The board also had evidence that a large consumer-products merger could stall when the two sides valued the business differently or imagined different management arrangements. 1 That combination created a better question than "Who will pay the most?" The question became "Which buyer can turn Gillette's assets into value while giving Gillette shareholders a credible share of that value?"
The proxy records Gillette's board considering a stand-alone future, another buyer, the value of the company, tax treatment, integration, exchange-ratio risk, and regulatory delay. 1 Calling any one of those options Gillette's proven BATNA would overstate the record. A reasonable reconstruction is narrower: Gillette could keep operating, continue to test buyers, or pursue a negotiated combination, while each path carried a different mix of execution risk and control loss.
Decision point 1: test the market before naming a price
Date: September 23 to November 16, 2004.
Decision: Gillette's board approved exploring a possible combination with P&G on September 23. On October 21, the board authorized contact with P&G. On November 5, Gillette chief executive James Kilts and P&G chief executive A.G. Lafley spoke, with Kilts describing a value range of roughly $50 to $60 per Gillette share. The companies met on November 12 and signed a confidentiality agreement with customary standstill provisions on November 16. 1
Viable alternative: Gillette could continue its strategic review, remain independent, or approach another consumer-products company. Those alternatives appear in the board's deliberations; the filing leaves the probability of a superior offer open. 1
Constraint and power asymmetry: Gillette owned a powerful brand portfolio, yet its review placed the company in a seller's process. P&G controlled access to its own stock currency, distribution system, and willingness to absorb integration risk. Gillette could create competition among potential buyers; P&G could decide whether the strategic fit justified paying inside Kilts' range.
Negotiated term: The confidentiality and standstill agreement created a controlled information exchange. P&G received limited access to personnel and technology for diligence, while Gillette preserved a structured process for testing P&G's interest. 1
Consequence: The parties moved from exploratory contact to a price discussion. The next test was P&G's willingness to convert strategic interest into a board-authorized offer.
The lesson at this stage concerns sequencing. Gillette shared enough information to let P&G assess the combination, while the standstill reduced the risk that diligence would become an open-ended solicitation. For a manager, the useful design question is simple: which information must a counterparty see before it can price the opportunity, and which rights should remain protected while that information moves?
Decision point 2: price kills the first round
Date: December 1–4, 2004.
Decision: On December 1, P&G's board reviewed the strategic fit, possible synergies, dilution and accretion, stock-price risk, credit-rating effects, regulatory issues, and alternative transactions that a Gillette acquisition might foreclose. The board authorized management to make an offer roughly equivalent to $50 per Gillette share. On December 2, P&G proposed an exchange ratio of 0.915 P&G shares for each Gillette share, a proposal valued slightly above $50 at the time. Gillette rejected the proposal, and the negotiations ended on December 4. 1
Viable alternative: P&G could raise the offer, keep talking about a cash value, or walk away. Gillette could accept the proposal, counter with a higher value, or return to its stand-alone and buyer-search options.
Constraint and power asymmetry: P&G had to protect the value of the stock it would issue and the earnings profile of the combined company. Gillette had already signaled a $50–$60 range, so the first proposal sat near the lower end of the seller's stated expectation. The exchange ratio also exposed Gillette shareholders to movements in P&G's share price before closing. 1
Negotiated term: The 0.915 ratio made the first offer a stock price translated into a fixed number of P&G shares. The structure placed part of the market risk on Gillette shareholders while preserving P&G's control over the amount of stock issued.
Consequence: Gillette's rejection ended the active talks. The price gap became a relationship and process problem as well as a valuation problem.
The record supports a precise reading of the failure. P&G had authorized a price around $50; Gillette had rejected the resulting ratio as inadequate. The evidence leaves open whether either chief executive had exhausted every possible price or whether a particular intermediary caused the breakdown. A manager facing the same moment should write down the reservation prices, the form of consideration, and the market risk before treating a rejected offer as a rejection of the whole deal.
Decision point 3: reopen the channel after the first gap
Date: December 17, 2004 to January 17, 2005.
Decision: P&G chief executive Lafley and P&G director Clayton Daley met Warren Buffett in Omaha on December 17. On January 4, investment banker Henry Paulson called Lafley to encourage continued communication. P&G's board authorized a resumption of discussions on January 11. At Lafley's request, former McKinsey managing director Rajat Gupta called Kilts on January 12, met him on January 13, and helped lead to a January 15 Lafley–Kilts conversation in which the parties agreed to recommence discussions. On January 17, the senior teams agreed to negotiate on a fixed exchange ratio. 1
Viable alternative: Both companies could let the December break stand. P&G could pursue another acquisition or wait for a better entry point. Gillette could continue its review or make a different buyer more attractive. The proxy records these categories of alternatives, while the path either company would have chosen remains open. 1
Constraint and power asymmetry: The first round had created a credibility problem. Gillette needed a reason to spend management time on a buyer that had started near the bottom of its stated range. P&G needed a way to reopen the discussion while preserving the credibility of the first board-approved price. Intermediaries supplied a communication path; each side retained its valuation position as it returned to the table.
Negotiated term: The parties agreed to negotiate using a fixed exchange ratio rather than a fixed dollar price. Gillette representatives indicated that they would consider one P&G share for each Gillette share, establishing a reference point for the next round. 1
Consequence: The parties changed the object of the negotiation. The next question became how many P&G shares Gillette shareholders should receive, with the market value of P&G shares moving the eventual dollar value.
A fixed ratio can solve one problem while assigning another. The ratio gives both sides a clean ownership formula and preserves the tax-free stock structure described in the proxy. 1 Gillette shareholders carry more exposure to P&G's share price between signing and closing. P&G carries the dilution and execution risk of issuing the shares. The parties were negotiating the risk allocation at the same time as the headline value.
Decision point 4: the ratio becomes the price
Date: January 18–27, 2005.
Decision: On January 18, Lafley offered 0.950 P&G shares per Gillette share. Kilts rejected the ratio as inadequate after discussions with Gillette's management and advisers. On January 21, Kilts proposed 0.975. Lafley agreed to recommend that ratio, subject to diligence and documentation. Between January 22 and January 27, the parties negotiated Kilts' post-merger employment, compensation, benefits, non-competition restrictions, and restrictions on selling P&G stock or exercising options. Both boards approved the transaction unanimously on January 27, when the companies signed the agreement. 1
Viable alternative: P&G could hold at 0.950 or walk away. Gillette could hold out for a one-for-one ratio, seek another buyer, or preserve the stand-alone option. The board record shows that each side considered valuation, risk, and alternatives; the expected value of an unpursued alternative remains unknown. 1
Constraint and power asymmetry: P&G had greater scale and would own approximately 71% of the combined company. Gillette shareholders would hold approximately 29%, giving Gillette's board a reason to focus on the share count and the future governance position. P&G's board also assessed dilution, stock-price risk, credit effects, and the cost of foreclosing other transactions. 1
Negotiated term: The 0.975 fixed ratio became the economic bridge. The executive agreement became a second bridge: Kilts would work for P&G during an integration period and then face non-competition and stock-transfer restrictions. 1
Consequence: A failed $50 negotiation became a signed all-stock merger valued at approximately $57 billion at announcement, with an 18% premium based on the January 27 closing prices. P&G also announced a plan to repurchase $18–$22 billion of its own stock over 12–18 months, a step intended to reduce the earnings-per-share effect of issuing stock while preserving the tax-free structure. 2
The negotiation therefore moved through two prices. The first price was a dollar reference that exposed an immediate gap. The second price was a share ratio tied to a broader package: ownership, taxes, integration leadership, stock-price risk, and a plan for P&G's dilution. The agreement reflects that whole package.
The third negotiator: regulatory approval
The signed agreement still had a powerful outside party to satisfy. The FTC's analysis identified four affected areas: adult battery-powered toothbrushes, at-home teeth whitening, men's antiperspirants and deodorants, and rechargeable toothbrushes. In adult battery-powered toothbrushes, the FTC said P&G and Gillette together accounted for more than 85% of U.S. sales. In at-home teeth whitening, the combined dollar share was about 80%. In men's antiperspirants and deodorants, the two companies were the largest suppliers and together held more than 50% of sales. Rechargeable toothbrushes were highly concentrated, with Gillette and Philips accounting for virtually all sales while P&G's exposure came through its Philips joint venture. 4
The remedy changed the asset perimeter. The consent order required P&G to divest the Crest SpinBrush business to Church & Dwight, Gillette to divest Rembrandt's at-home teeth-whitening business, and Gillette to divest Right Guard and other specified deodorant assets. The order also required an amendment to the P&G–Philips joint venture so Philips could independently market and sell IntelliClean products and both companies could develop future rechargeable toothbrush products. 5
That remedy makes regulatory review part of the negotiation's economics. The parties were bargaining over a combined portfolio whose final contents depended on a government decision. The FTC analysis says the divestiture buyers had to preserve competition and avoid creating new competitive problems. 4
The merger agreement allocated some of that uncertainty in advance. The outside date was November 30, 2005, with an automatic extension to February 28, 2006 when only antitrust or other government approvals remained. Gillette could terminate for a superior proposal after notice, while P&G received a four-business-day matching right. In specified circumstances, Gillette's termination fee was $1.92 billion. The parties agreed to use commercially reasonable efforts and could be required to divest assets, while the agreement set provisions around assets that generated more than $1.9 billion in 2004 net sales. 1
Decision point: sign with a remedy package still subject to regulatory review, or demand more certainty before signing.
Viable alternative: The parties could delay signing, narrow the portfolio in advance, or abandon the transaction. The record supports the existence of regulatory risks and negotiated closing protections; each board's private probability assigned to approval remains undisclosed. 1
Constraint and power asymmetry: The FTC could change which assets survived the transaction. P&G and Gillette could negotiate effort standards and termination rights, yet neither company controlled the regulator's definition of competition. 14
Negotiated term: The outside date, matching right, termination fee, divestiture obligations, and closing conditions turned regulatory uncertainty into specific rights and deadlines.
Consequence: The deal could proceed toward closing with an explicit allocation of delay, breakup, and asset-sale risk. The regulatory remedy later required the sale of businesses that the headline merger rationale had included.
What happened after signing
The merger closed on October 1, 2005. P&G issued 962 million common shares and 79 million stock options in exchange for Gillette awards. The 2007 Form 10-K records approximately $53.43 billion of total purchase consideration under purchase accounting. 3
Regulatory approval required the divestiture of SpinBrush, Rembrandt, Right Guard, and other Gillette deodorant brands. P&G initially kept the acquired businesses in a separate Gillette Global Business Unit. Effective July 1, 2007, P&G reorganized the former Gillette businesses into the Beauty and Household Care groups, with Braun combined with Blades and Razors in the Grooming segment. 3
By the fiscal year ended June 30, 2007, approximately 5,000 positions had been eliminated through the Gillette integration, including approximately 2,200 during that fiscal year. P&G's filing also warned that failure to deliver expected cost and growth synergies could adversely affect business results. 3
The post-close record gives the negotiation a sharper ending. P&G acquired a global platform whose most recent pre-acquisition-year sales were $10.5 billion, issued stock to complete the exchange, sold overlapping businesses to secure approval, reorganized the acquired units, and removed duplicated positions. 3 The signed price described one transaction. The operating result depended on the assets that survived review, the leaders who managed integration, and the cost savings P&G could actually produce.
Five reusable frameworks
1. The consideration-risk map
Start by separating the headline price from the instrument that delivers it. A cash price fixes the seller's dollar amount at closing; a fixed stock ratio fixes the number of shares and leaves the dollar value exposed to the buyer's share price. The P&G–Gillette negotiation moved from a roughly $50 reference point and a 0.915 proposal to a 0.975 ratio. 1
Use it when: the buyer offers stock, earn-outs, contingent value, or another instrument whose value can move.
Ask: who carries market, performance, or timing risk between signing and closing?
Limit: the map describes risk allocation. A seller's acceptance still depends on its own exposure and alternatives.
2. The control-and-transition bridge
List the rights that determine whether the promised value can be captured: operating control, reporting lines, product autonomy, executive roles, non-compete terms, voting power, and the ability to sell or exercise equity. P&G and Gillette negotiated Kilts' integration-period employment and post-employment restrictions alongside the exchange ratio. Gillette shareholders were set to own approximately 29% of the combined company, while P&G shareholders retained approximately 71%. 1
Use it when: the seller's value rests on people, creative autonomy, technical knowledge, or a fragile reporting relationship.
Ask: which person or team controls the capability that makes the purchase price worthwhile during the first 12 to 24 months?
Limit: transition terms can preserve operating knowledge while still creating conflicts of interest. A contract can allocate authority; cooperation still depends on the people involved.
3. The regulatory-gate model
Treat the regulator as a participant with a veto over the asset perimeter. List each overlapping product, the evidence that may draw review, the possible divestiture, the buyer for that divestiture, and the value left after the remedy. The FTC's review covered four product areas and led to divestitures plus an amendment to the P&G–Philips joint venture. 45
Use it when: a third party can delay closing, require sales, or alter the rights attached to the acquired business.
Ask: what does the deal become if the regulator removes the asset that carries the synergy?
Limit: market-share screens address one part of the legal question. The model organizes exposure; counsel and the regulator determine the governing standard.
4. The closing-certainty package
Convert uncertainty into terms that can be priced: outside date, extension trigger, effort standard, divestiture ceiling, matching right, termination fee, and conditions to closing. The P&G–Gillette agreement used each of those devices in some form. 1
Use it when: a signed agreement still faces shareholder, antitrust, financing, or cross-border approval.
Ask: which event ends the deal, who gets to extend the clock, and who pays for the right to leave?
Limit: a detailed package can allocate risk while leaving the underlying uncertainty in place. A large termination fee may deter alternatives while the transaction's underlying value continues to deteriorate.
5. The BATNA-under-time-pressure test
Write three columns before the next offer: what the record proves, what the party can do next, and what the party would lose by waiting. In this case, the proxy documents Gillette's stand-alone and buyer-search considerations, P&G's concern over dilution and foregone alternatives, and the January reopening. Those facts support a map of alternatives. The precise private BATNA value remains undisclosed. 1
Use it when: a negotiation restarts after a rejection or when an intermediary asks the parties to repair a damaged channel.
Ask: what becomes more valuable by waiting, and what becomes harder to recover?
Limit: the test keeps analysis honest. It maps existing alternatives; a buyer, a better market, or a credible alternative still has to be developed.
Manager's takeaway
The P&G–Gillette agreement became possible after the parties changed more than the number. They reopened communication, shifted from a fixed dollar reference to a fixed share ratio, added executive-transition terms, and wrote regulatory delay and asset sales into the closing package. The final transaction still depended on divestitures and integration work that the announcement could only estimate.
In a live deal, ask four questions before arguing over the next increment of price:
- Who carries the risk that the consideration changes in value?
- Who controls the people, rights, or capability that create the promised value?
- Which third party can remove an asset or delay closing?
- Which contract terms make the agreed price executable?
A higher headline number answers only the first question, and sometimes answers it badly.
References
- 1
- 2
- 3
- 4
- 5FTC consent order
ftc.gov
This story was produced automatically by a channel. One sentence is all it takes for Neodrop to keep producing for you.